Defensins: Key players or bystanders in infection, injury, and repair in the lung?

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages 1131-1138

  Van Watering, Sandra ^a   Sterk, Peter J ^a   Rabe, Klaus F ^a   Hiemstra, Pieter S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antimicrobial peptides; Defensins; Epithelial cells; Host defense; Immune response; Infection; Inflammatory lung disease; Innate immunity; Neutrophils

Indexed keywords

CHEMOKINE; DEFENSIN; HISTAMINE; ISOPROTEIN;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ASTHMA; BACTERIUM ADHERENCE; BRONCHUS REACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; IMMUNOPATHOGENESIS; LUNG INFECTION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RESPIRATORY EPITHELIUM; REVIEW; SEQUENCE ANALYSIS; TISSUE REPAIR;

EID: 0033452745     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70004-7     Document Type: Review

References (57)

1. 1. Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993;11:105-28.
2. 2. Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol 1995;58:128-36.
3. 3. Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998;152:1247-58.
4. 4. Diamond G, Bevins CL. β-Defensins: endogenous antibiotics of the innate host defense response. Clin Immunol Immunopathol 1998;88:221-5.
5. 5. Russell JP, Diamond G, Tarver AP, Scanlin TF, Bevins CL. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect Immun 1996;64:1565-8.
6. 6. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG. hBD-1: a novel β-defensin from human plasma. FEBS Lett 1995;368:331-5.
7. 7. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553-60.
8. 8. McCray PB Jr, Bentley L. Human airway epithelia express a β-defensin. Am J Respir Cell Mol Biol 1997;16:343-9.
9. 9. Harder J, Bartels J, Christophers E, Schröder JM. A peptide antibiotic from human skin. Nature 1997;387:861.
10. 10. Palfree RG, Sadro LC, Solomon S. The gene encoding the human corticostatin HP-4 precursor contains a recent 86-base duplication and is located on chromosome 8. Mol Endocrinol 1993;7:199-205.
11. 11. Linzmeier R, Michaelson D, Liu L, Ganz T. The structure of neutrophil defensin genes. FEBS Lett 1993;321:267-73.
12. 12. Sparkes RS, Kronenberg M, Heinzmann C, Daher KA, Klisak I, Ganz T, et al. Assignment of defensin gene(s) to human chromosome 8p23. Genomics 1989;5:240-4.
13. 13. Wilde CG, Griffith JE, Marra MN, Snable JL, Scott RW. Purification and characterization of human neutrophil peptide 4, a novel member of the defensins family. J Biol Chem 1989;264:11200-3.
14. 14. Valore EV, Martin E, Harwig SSL, Ganz T. Intramolecular inhibition of human defensin HNP-1 by its propiece. J Clin Invest 1996;97:1624-9.
15. 15. Liu L, Zhao C, Heng HH, Ganz T. The human β-defensin-1 and α-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics 1997;43:316-20.
16. 16. Liu L, Wang L, Zhao C, Heng HHQ, Schutte BC, McCray PB Jr, et al. Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 1998;222:237-44.
17. 17. Valore EV, Park CH, Quayle AJ, Wiles KR, McGray PB, Ganz T. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998;101:1633-42.
18. 18. Hiratsuka T, Nakazato M, Date Y, Ashitani J, Minematsu T, Chino N, et al. Identification of human β-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Bioehem Biophys Res Commun 1998;249:943-7.
19. 19. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BD, et al. Production of β-defensins by human airway epithelia. Proc Natl Acad Sci USA 1998;95:14961-6.
20. 20. Valore EV. Quayle AJ, Robbins A, Ganz T. A human β-defensin is produced by urogenital epithelia [abstract]. J Invest Med 1996;44:268.
21. 21. Liu L, Heng HH, Zhao C, Ganz T. Human α-and β-defensins evolved from a common pre-mammalian ancestor peptide [abstract]. J Invest Med 1996;44:294.
22. 22. Zhao C, Wang I, Lehrer RI. Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996;396:319-22.
23. 23. Hill CP, Yee J, Selsted ME, Eisenberg SP. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 1991;251:1481-5.
24. 24. Kagan BL, Selsted ME, Ganz T, Lehrer RI. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci USA 1990;87:210-4.
25. 25. Bals R, Wang X, Wu Z, Freeman T, Zasloff M, Wilson JM. Human β-defensin2 is a salt sensitive peptide antiobiotic expressed in human lung. J Clin Invest 1998;102:874-80.
26. 26. Panyutich AV, Panyutich EA, Krapivin A, Baturevich EA, Ganz T. Plasma defensin concentrations are elevated in patients with septicemia and bacterial meningitis. J Lab Clin Med 1993;122:202-7.
27. 27. Ashitani JMH, Nakazato M, Ihi T, Mason GR, Kagan BL, Koike K, et al. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. Eur Respir J 1998;11:104-11.
28. 28. Soong LB, Ganz T, Ellison A, Caughey GH. Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res 1997;46:98-102.
29. 29. Panyutich AV, Hiemstra PS, van Wetering S, Ganz T. Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol 1995;12:351-7.
30. 30. Paone G, Rouhani F, Brantley M. Potential role of human neutrophil defensins in lung destruction of individuals with α-1-antitrypsin deficiency [abstract]. Am J Respir Crit Care Med 1997;155:853.
31. 31. Ashitani J, Mukae H, Ihiboshi H, Taniguchi H, Mashimoto H, Nakazato M, et al. Defensin in plasma and in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome. Nihon Kyobu Shikkan Gakkai Zasshi 1996;34:1349-53.
32. 32. van Wetering S, Mannesse-Lazeroms SPG, van Sterkenburg MAJA, Daha MR, Dijkman JH, Hiemstra PS. Effect of defensins on IL-8 synthesis in airway epithelial cells. Am J Physiol 1997;272:L888-96
33. 33. Paone G, Krein P, Rouhani F, Brantly ML. Human neutrophil peptides stimulate alveolar macrophage production of LTB4 and IL-8 [abstract]. Am J Respir Crit Care Med 1999;159:511.
34. 34. Territo MC, Ganz T, Selsted ME, Lehrer RI. Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 1989;84:2017-20.
35. 35. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, et al. Identification of defensin-1, defensin-2 and cap37/azurocidin as T-cell chemoattractant proteins released from interleukin-8 stimulated neutrophils. J Biol Chem 1996;271:2935-40.
36. 36. Welling MM, Hiemstra PS, van den Barselaar MTh, Paulusma-Annema A, Nibbering PH, Pauwels EKJ, et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest 1998;102:1583-90.
37. 37. Lillard JW Jr, Boyaka PN, Chertov O, Oppenheim JJ, McGhee JR. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci USA 1999;96:651-6.
38. 38. Fick RB, Metzger WJ, Richardson HB, Zavala DC, Mosley PL, Schoderbek WE, et al. Increased bronchoalveolar permeability after allergen exposure in sensitive asthmatics. J Appl Physiol 1987;63:1147-55.
39. 99mTc-DPTA aerosol deposition and clearance in COPD, interstitial disease, and smokers. J Thorac Imaging 1986;1:54-60.
40. 40. van Wetering S, Mannesse-Lazeroms SPG, Dijkman JH, Hiemstra PS. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol 1997;62:217-26.
41. 41. van Wetering S, van der Linden AC, van Sterkenburg MAJA, Hiemstra PS. Effects of neutrophil defensins and elastase on the production of antileukoprotease (ALP) by primary bronchial epithelial cells in vitro: modulation by a1-proteinase inhibitor [abstract]. Am J Respir Crit Care Med 1998;157:570.
42. 42. Morrison HM, Kramps JA, Burnett D, Stockley RA. Lung lavage fluid from patients with a α1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci 1987;72:373-81.
43. 43. Trefz G, Schließer J, Heck B, Schulz V, Eby GA. α1 -Proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema. Clin Invest 1992;70:269-76.
44. 44. van Wetering S, Rahman I, Hiemstra PS, MacNee W. Role of intracellular glutathione in neutrophil defensin-induced IL-8 synthesis and cytotoxicity in airway epithelial cells. Eur Respir J 1998;12:420s.
45. 45. Lichtenstein AK, Ganz T, Selsted ME, Lehrer RI. Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins. Cell Immunol 1988;114:104-16.
46. 46. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 1996;154:1055-60.
47. 47. Rahman I, Li XY, Donaldson K, Harrison DJ, MacNee W. Gluthathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol 1995;269:L28592.
48. 48. Gorter A. Eijk PP, van Wetering S, Hiemstra PS, Dankert J, van Alphen L. Stimulation of adherence of Haemophilus influenzae to human lung epithelial cells by antimicrobial neutrophil defensins. J Infect Dis 1998;178:1067-74.
49. 49. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH. Antibacterial activity of antileukoprotease. Infect Immun 1996;64:4520-4.
50. 50. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843-52.
51. 51. Coyle AJ, Uchida DA, Ackerman SJ, Mitzner W, Irvin CG. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am J Respir Crit Care Med 1994;150:S63-71.
52. 52. van Overveld FJ, Hiemstra PS, De Backer WA, Vermeire PA. Human mast cells can be activated by defensins. Eur Respir J 1995;6:534s.
53. 53. van Gessel S, Folkerts G, van Wetering S, Hiemstra PS, Nijkamp F. Neutrophil defensins induce hyperresponsiveness of guinea pig airways [abstract]. Clin Exp Allergy 1999. In press.
54. 54. van den Berg R. Faber-Krol MC, van Wetering S, Hiemstra PS, Daha MR. Inhibition of activation of the classical pathway of complement by human neutrophil defensins. Blood 1998;92:3898-903.
55. 55. Higazi AA, Barghouti II, Abu-Much R. Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils. A role for defensin. J Biol Chem 1995;270:9472-7.
56. 56. Murphy CJ, Foster BA, Mannis MJ, Selsted ME, Reid TW. Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol 1993;155:408-13.
57. 57. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996;85:229-36. airway wall remodeling. (J Allergy Clin Immunol 1999;104:1139-46.)